granted
-
Biologics
Amedica Granted 180-Day Extension by NASDAQ to Regain Compliance with Minimum Bid Price Rule
SALT LAKE CITY, August 20, 2015 – Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a…
Read More » -
Prochymal New Drug Submission Granted Priority Review by Health Canada
COLUMBIA, Md.–(BUSINESS WIRE)–Osiris Therapeutics, Inc. (NASDAQ: OSIR) announced today that the Biologics and Genetic Therapies Directorate of Health Canada has completed its…
Read More »